Doctor Search

New Search
Thomas W. Axelrad MD, PhD
Practice accepting new patients.

Thomas W. Axelrad MD, PhD

(337) 494-4900
Primary Specialties
  • Orthopedics
Secondary Specialties
  • Orthopedic Trauma
Affiliations
  • Memorial Medical Group

Primary Office

Address:
1717 Oak Parl Boulevard
3rd Floor
Lake Charles, LA 70601
Phone:
(337) 494-4900
Fax:
(337) 494-4936
Web:
View Web Page
View Health Grades Page

Physician Bio

Licensures

  • Louisiana

Publications

  • Theodossiou C, Skrepnik N, Robert £0, Prasad C, Axelrad TW, Schapira DV, Hunt JD. Propyithiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice, Cancer. 1999 Oct 1 5;86(8): 1596-1601
  • Deo DD, Axelrad TW, Robert EG, Marcheselli V, Bazan NG, Hunt 3D. Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. 3 Biol Chem. 2002 Jun 14;277(24):2 1237-45.
  • Hunt 3D, Strimas A, Martin JE, Eyer M, Haddican M, Luckett BO, Ruiz B, Axelrad TW, Backes WL, Fontham ET. Differences in KRAS mutation spectrum in lung cancer cases between African Americans and Caucasians after occupational or environmental exposure to known carcinogens. Cancer Epideiniol I3iomarkers Prey. 2002 Nov; 11(11): 1405-1412.
  • Axelrad TW, Deo DD, Ottino P, Van Kirk I, l3azan NG, l3azan HE, Hunt 3D. Platelet activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration. FASEB J. 2004 Mar; I 8(3):568-570.
  • Ottino P, He JC, Axelrad TW, Bazan 1-IEP. PAF-induced Furin and MT1- MMP Expression is Independent of MMP-2 Activation in Comeal Myofibroblasts. IOVS. 2005 Feb;46(2):487-96.
  • Axelrad TW, Kakar S, Einhorn TA, New technologies for the eithanccment of skeletal repair. Injury. 2007 Mar;38 Suppplement 1: S49-62.
  • Axelrad TW, Einhorn TA, New l3iotechnologies for the Stimulation of Bone Repair Italian Journal of Orthopaedics and Traumatology, 2007;33 Supplement I :S262-S266.
  • Axelrad TW, Steen B, Creevy WR, Lowenberg DW, Einhorn TA. Heterotopic Ossification Following use of Commercially Available rhBMPs in Four Patients. JBJSBr, 2008 Dec;90(12): 1617-1622.
  • Axelrad TW, Einhorn TA. Bone Moiphogenetic Proteins in Orthopaedic Surgery. Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6): 48 1-488.
  • Axelrad TW, Einhorn TA. Use of Clinical Assesment Tools in Evaluation of Fracture Healing. Injury. 2010 Dec 8.
  • Deehan A, Axelrad TW, Kaye E, Foster TB, Meta-Analysis of Single vs Double Row Rotator Cuff Repairs. Submitted Am 3 Sports Med.

Affiliates & Groups

  • Orthopaedic Specialists
  • Hip Center of Louisiana
  • A part of the Memorial Medical Group
    www.lcmmg.com

Highlights

As an orthopaedic trauma surgeon, Dr. Axelrad is experienced in the treatment of pelvic and acetabular injuries, as well as joint reconstruction and replacement. He is also experienced in hip replacement, resurfacing and osteomy, as well as in the treatment of bone infections and nonunions. He has published extensive research on bone healing, and has presented at various medical assemblies around the country. Orthopedic trauma involves more significant injuries with multiple broken bones, compound fractures and fractures near a joint, and fractures of the pelvis that are more difficult to treat, and benefit the most from specialized care. Additionally, problems with healing including nonunions, infections (osteomyelitis) and healing with poor alignment (malunion) are often treated by fracture specialists.

Conditions & Diseases Treated

  • Orthopedic Trauma
  • Orthopedic Surgery
  • Joint replacement
  • Hip replacement
  • Hip & Pelvic Fractures
  • Bone infection
  • Bone non-union
  • Osteotomy

Groups

  • Louisiana State Medical Society
  • Massachusetts Medical Society

Accepted Health Plans

  • - Please contact your physician's office for a list of insurances accepted.